About 1 result found for searched term "1228763-95-8" (0.132 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21501 | Monalizumab | Checkpoint |
| IPH2201 | ||
| Monalizumab is a first-in-class immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab can be used in the study of head and neck squamous cell carcinoma (HNSCC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
